HIF1A and hepatocellular carcinoma: To better clarify the biological and clinical role of SIRT-3, p-mTOR and HIF-1α in HCC, we evaluated the expression of these three markers in tissue from two cohorts of HCC patients (one at early stage and one at advanced stage) in relation with the presence of metabolic dysfunctions, chronic treatment with metformin and clinical outcome.